Description
Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth.
With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products. The implantable/injectable delivery drug market is a expected to grow to over $12 billion by 2010.
Kalorama’s Drug Delivery Markets. Edition 2 Volume II: Implantable / Injectable Systems, the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:
- Needle-Free delivery systems
- Implantable delivery systems
- Targeted Delivery systems
- Sustained-release drug delivery
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
- Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
- Current Revenue and Forecasts to 2010 By Needle-Free and Other Implantable/Injectable Segments
- Extensive Discussion of Implantable/Injectable Trends and Developments
- New Products in Development
Kalorama’s trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the implantable/injectable delivery drug market — as well as the whole Kalorama Series on Drug Delivery Systems essential.
